Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ: OGXI
Date6/2013
Raised
Post IPO Valuation

General Information

Websiteoncogenex.com
Twitter@OncoGenexPharma
CategoryBioTech
Phone425 6861500
Employees

Offices

Bothell, USA
1522 217th Place SE
Suite 100
Bothell, WA, 98021
USA

People

President & Chief Executive Officer
Board Member
Director

Funding

TOTAL $10M
FUNDING TOTAL $10M
Venture Round, 1/2010
$10M

Tags

OncoGenex

OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Recent Milestones

  • Stock
    Went public with stock symbol NASDAQ: OGXI. (6/13/13)
    Posted 6/13/13 at 11:34pm
  • Dollar
    OncoGenex received $10M in Venture Round funding. (1/4/10)
    Posted 12/2/13 at 11:16pm via sec.gov
  • Check
    OncoGenex added Scott Cormack as President & Chief Executive Officer.
    Posted 6/13/13 at 11:27pm

Videos

Screenshots

OncoGenex screenshot
Above: Homepage
Uploaded: 6/14/13

Stock Price

Sources

  1. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy